We are live on ! Find out more
SAM

Symphony Asset Management Portfolio holdings

AUM $309M
1-Year Est. Return 9.39%
This Fund
S&P 500
This Quarter Est. Return
+3.97%
1 Year Est. Return
+9.39%
3 Year Est. Return
+21.56%
5 Year Est. Return
+39.45%
10 Year Est. Return
AUM
$803M
AUM Growth
-$167M
Cap. Flow
-$362M
Cap. Flow %
-45.09%
Top 10 Hldgs %
27.08%
Holding
479
New
83
Increased
131
Reduced
119
Closed
87

Top Sells

Rank Stock Value
1
JAZZ icon
Jazz Pharmaceuticals
JAZZ
+$3.98M
2
SEMG
SEMGROUP CORPORATION
SEMG
+$3.45M
3
M icon
Macy's
M
+$3.19M
4
UNP icon
Union Pacific
UNP
+$3.13M
5
SM icon
SM Energy
SM
+$3.01M

Sector Composition

Rank Sector Weight
1 Healthcare 8.54%
2 Technology 8.04%
3 Consumer Discretionary 7.25%
4 Industrials 7.09%
5 Financials 6.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CYH icon
126
Community Health Systems
CYH
$385M
$1.24M 0.15%
27,753
-14,702
-35% -$629K
PWR icon
127
Quanta Services
PWR
$93.9B
$1.23M 0.15%
43,456
-59,051
-58% -$1.85M
KCG
128
DELISTED
KCG Holdings, Inc.
KCG
$1.21M 0.15%
+103,978
New +$1.14M
CRM icon
129
Salesforce
CRM
$134B
$1.2M 0.15%
20,148
+4,883
+32% +$288K
CNW
130
DELISTED
CON-WAY INC.
CNW
$1.18M 0.15%
+23,978
New +$1.11M
AMZN icon
131
Amazon
AMZN
$2.5T
$1.16M 0.14%
74,560
-6,000
-7% -$93.5K
AKAM icon
132
Akamai
AKAM
$16.8B
$1.13M 0.14%
+17,900
New +$1.08M
SCHW
133
Charles Schwab
SCHW
$177B
$1.1M 0.14%
36,619
+358
+1% +$10.2K
SLXP
134
CALL
DELISTED
SALIX PHARMACEUTICALS LTD DEL
SLXP
$1.09M 0.14%
9,500
-7,500
-44% -$909K
APTV icon
135
Aptiv
APTV
$12B
$1.08M 0.13%
14,895
-3,644
-20% -$251K
VIAB
136
DELISTED
Viacom Inc. Class B
VIAB
$1.08M 0.13%
14,324
-1,220
-8% -$89.2K
ESRX
137
DELISTED
Express Scripts Holding Company
ESRX
$1.07M 0.13%
12,673
+124
+1% +$9.69K
LMT icon
138
Lockheed Martin
LMT
$134B
$1.07M 0.13%
+5,574
New +$1.03M
UAL icon
139
United Airlines
UAL
$38.4B
$1.07M 0.13%
+15,964
New +$884K
VRTX icon
140
Vertex Pharmaceuticals
VRTX
$121B
$1.05M 0.13%
8,841
-3,813
-30% -$429K
GBX icon
141
The Greenbrier Companies
GBX
$1.61B
$1.04M 0.13%
+19,389
New +$1.1M
LVLT
142
DELISTED
Level 3 Communications Inc
LVLT
$1.04M 0.13%
+21,024
New +$971K
GIS icon
143
General Mills
GIS
$19.2B
$1.02M 0.13%
19,106
-10,010
-34% -$518K
AMTD
144
DELISTED
TD Ameritrade Holding Corp
AMTD
$1.02M 0.13%
28,450
+5,894
+26% +$200K
BMY icon
145
Bristol-Myers Squibb
BMY
$127B
$1.01M 0.13%
17,037
-3,987
-19% -$225K
QCOM icon
146
Qualcomm
QCOM
$176B
$999K 0.12%
13,441
-14,313
-52% -$1.05M
MEOH icon
147
Methanex
MEOH
$4.32B
$997K 0.12%
21,755
-49,323
-69% -$2.69M
PM icon
148
Philip Morris
PM
$301B
$991K 0.12%
12,170
+4,929
+68% +$423K
KRFT
149
DELISTED
KRAFT FOODS GROUP INC COM STK (VA)
KRFT
$950K 0.12%
15,154
+5,307
+54% +$311K
WSO icon
150
Watsco Inc
WSO
$14.9B
$945K 0.12%
8,830
+3,934
+80% +$391K

Similar funds

Symphony Asset Management's Q4 2014 Portfolio in Review

As of Q4 2014, Symphony Asset Management held 479 positions worth $803M, down 17% from $970M the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Symphony Asset Management withdrew a net $362M in Q4 2014, closing 87 positions and reducing 119 holdings. Its most notable exit was Macy's, an estimated $3.19M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 8.5% of assets, up from 7.5% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Symphony Asset Management opened a new position in Red Hat Inc worth $3.67M.

  • Symphony Asset Management's largest Q4 2014 buy was Red Hat Inc: 53,100 shares worth $3.67M.
  • Symphony Asset Management added most to State Street SPDR S&P 500 ETF Trust in Q4 2014, an estimated $3.06M increase.
  • Symphony Asset Management's biggest Q4 2014 reduction was Jazz Pharmaceuticals, cutting an estimated $3.98M.
  • Symphony Asset Management fully exited Macy's in Q4 2014, selling an estimated $3.19M.
  • Symphony Asset Management's ten largest holdings make up 27% of its $803M portfolio in Q4 2014.
  • Symphony Asset Management opened 83 new positions and closed 87 in Q4 2014.
  • Symphony Asset Management's portfolio value fell 17% quarter-over-quarter to $803M.

Based on Symphony Asset Management's 13F filing for Q4 2014, filed 9 Feb 2015.